Literature DB >> 29063108

Regulation of iron metabolism by hypoxia-inducible factors.

Man-Man Xu1, Jun Wang1, Jun-Xia Xie2.   

Abstract

Hypoxia-inducible factors (HIFs) are central mediators of cellular adaption to hypoxia. The heterodimeric HIF transcription factors consist of HIF-α and HIF-β, that form functional HIFs. Mammals contain HIF-1α, HIF-2α, and HIF-3α. HIFs play a key role in iron metabolism by regulating the expression of iron-related proteins, such as divalent metal transporter 1 (DMT1), ferroportin 1 (FPN1), duodenal cytochrome b (Dcytb), and transferrin receptor (TfR). Hepcidin and iron regulatory proteins (IRPs), the central mediators for systematic and intracellular iron homeostasis, are also regulated by HIFs. In this review, we summarized the regulatory effects of HIFs on iron-related proteins, thus providing insights into the control of HIFs as therapeutic strategies for some iron related disorders.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29063108

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  14 in total

Review 1.  Cobalt in athletes: hypoxia and doping - new crossroads.

Authors:  Anatoly V Skalny; Irina P Zaitseva; Yordanka G Gluhcheva; Andrey A Skalny; Evgeny E Achkasov; Margarita G Skalnaya; Alexey A Tinkov
Journal:  J Appl Biomed       Date:  2018-11-23       Impact factor: 1.797

2.  HIF1α-Dependent Induction of TFRC by a Combination of Intestinal Inflammation and Systemic Iron Deficiency in Inflammatory Bowel Disease.

Authors:  Raphael R Fagundes; Arno R Bourgonje; Shixian Hu; Ruggero Barbieri; Bernadien H Jansen; Nienke Sinnema; Tjasso Blokzijl; Cormac T Taylor; Rinse K Weersma; Klaas Nico Faber; Gerard Dijkstra
Journal:  Front Physiol       Date:  2022-06-08       Impact factor: 4.755

Review 3.  Friend or Foe: The Relativity of (Anti)oxidative Agents and Pathways.

Authors:  András Szarka; Tamás Lőrincz; Péter Hajdinák
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

4.  Dysregulation of iron homeostasis and methamphetamine reward behaviors in Clk1-deficient mice.

Authors:  Peng-Ju Yan; Zhao-Xiang Ren; Zhi-Feng Shi; Chun-Lei Wan; Chao-Jun Han; Liu-Shuai Zhu; Ning-Ning Li; John L Waddington; Xue-Chu Zhen
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

5.  Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease.

Authors:  Tadao Akizawa; Iain C Macdougall; Jeffrey S Berns; Hiroyasu Yamamoto; Megumi Taguchi; Kazuma Iekushi; Thomas Bernhardt
Journal:  Nephron       Date:  2019-08-06       Impact factor: 2.847

Review 6.  The evolving landscape of N6-methyladenosine modification in the tumor microenvironment.

Authors:  Yunru Gu; Xi Wu; Jingxin Zhang; Yuan Fang; Yutian Pan; Yongqian Shu; Pei Ma
Journal:  Mol Ther       Date:  2021-04-09       Impact factor: 11.454

Review 7.  Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis.

Authors:  Núria DeGregorio-Rocasolano; Octavi Martí-Sistac; Teresa Gasull
Journal:  Front Neurosci       Date:  2019-02-19       Impact factor: 4.677

Review 8.  Transferrin Receptors in Erythropoiesis.

Authors:  Cyrielle Richard; Frédérique Verdier
Journal:  Int J Mol Sci       Date:  2020-12-19       Impact factor: 5.923

9.  HIF-1α as a Target Molecule in the Use of Triazino-Indole Derivative on the Acoustic Trauma Model.

Authors:  Vladimir L Pastushenkov; Leonid G Buynov; Maksim S Kuznetsov; Vladimir V Dvorianchikov; Lev A Glaznikov; Aleksandr L Pastushenkov
Journal:  Audiol Res       Date:  2021-07-15

10.  Jian-Pi-Yi-Shen Regulates EPO and Iron Recycling Protein Expressions in Anemic Rats with Chronic Kidney Disease: Accumulation of Hypoxia Inducible Factor-2α via ERK Signaling.

Authors:  Fochang Wang; Huimin Yu; Shiying Huang; Lin Zheng; Ping Zheng; Shangbin Zhang; Shunmin Li; Jianping Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.